A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation

NCT02768168 ·Status: COMPLETED ·Phase: NA

Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication (REaCT-dexamethasone)

NCT02815319 ·Status: COMPLETED ·Phase: PHASE4

Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction

NCT02349763 ·Status: COMPLETED ·Phase: PHASE3

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

NCT04817189 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome

NCT02846493 ·Status: UNKNOWN ·Phase: PHASE2

Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting

NCT07124195 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

NCT00687011 ·Status: COMPLETED ·Phase: PHASE4

Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients

NCT01370408 ·Status: COMPLETED ·Phase: PHASE2

Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation

NCT00314743 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Reducing Dexamethasone Around Docetaxel Infusion

NCT02776436 ·Status: COMPLETED ·Phase: PHASE1

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

NCT01275664 ·Status: TERMINATED ·Phase: NA

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

NCT00553059 ·Status: COMPLETED ·Phase: PHASE3

Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis

NCT00869310 ·Status: TERMINATED ·Phase: PHASE3

A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity

NCT00176553 ·Status: TERMINATED ·Phase: NA

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

NCT00293384 ·Status: COMPLETED ·Phase: NA

Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting

NCT07246070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Granisetron Transdermal Patch System for Prevention of CINV by CapeOX

NCT05325190 ·Status: UNKNOWN ·Phase: PHASE2

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

NCT05564286 ·Status: COMPLETED ·Phase: PHASE3

HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents

NCT06554184 ·Status: COMPLETED ·Phase: PHASE3

Dexamethasone for the Prophylaxis of Pain Flare Study

NCT00438828 ·Status: COMPLETED ·Phase: PHASE1

Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy

NCT03177317 ·Status: COMPLETED ·Phase: NA

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

NCT00004219 ·Status: UNKNOWN ·Phase: PHASE3

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

NCT01700140 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment

NCT06118710 ·Status: RECRUITING ·Phase: PHASE4

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

NCT01596400 ·Status: COMPLETED ·Phase: PHASE1